Midterm 1 Flashcards
Diagnostic drug/agent
Chemical used to facilitate an examination and/or diagnosis
Therapeutic drug/agent
Chemical used to treat a disorder of the eye or vision
Medical conditions to consider when prescribing medications
Renal/hepatic disease, cardiovascular disease, respiratory disease, thyroid disease, DM, CNS conditions, affective/mental health disorders, pregnancy
Why do we ask patients about medications they are taking?
Concerned about drug-to-drug interactions (including OTC), drug allergies, and ocular side effects of those medications
Local adverse reactions from TOPICAL Medications
Cutaneous, conjunctiva, cornea, intraocular pressure, crystalline lens, retina, macula edema, bulbar follicles, corneal verticillata, PSC, etc.
Systemic adverse reactions from TOPICAL medications
Impact HR, respiration
Ocular adverse effects from SYSTEMIC medication
Dry eye, corneal verticillata, PSC, retinal toxicity, optic neuropathy, papilledema, accommodation issues
Special populations to consider
Pregnant/lactating patients, pediatric patients, geriatric patients
Pregnancy category A
- adequate well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy
- very few drugs fall in this category
Pregnancy category B
- animal reproductive studies have failed to demonstrate a risk to the fetus, and there are no adequate human studies
- fair number of drugs in this category
Pregnancy category C
animal reproductive studies have shown an adverse effect on the fetus and there are no adequate human studies; potential benefits may warrant use of the drug in pregnant women despite potential risks
Pregnancy category D
- there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies
- potential benefits may warrant use of the drug in pregnant women despite potential risks
Pregnancy category X
- studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk
- risks involved in the use of the drug in pregnant women clearly outweigh potential benefits
Geriatric patient considerations when prescribing
- eyelid laxity may increase retention time and increase systemic absorption
- arthritis/tremor may make instillation of topical meds more difficult
- cognitive difficulties may lead to poor medication adherence
Pediatric dosing: Young’s Rule formula
Age (years) / (Age + 12) X Adult dose = pediatric dose
Pediatric dosing: Webster’s Rule
- based on age and the fact that children are heavier now
- (age + 1) / (age + 7) X adult dose
Pediatric dosing: Clark’s rule***
- based on weight, making it more accurate
- weight in pounds / 150 X adult dose
Properties of outer lipid layer of tear film
Readily washed away with irrigation and tearing; not very stable
Properties of middle aqueous layer
- 95% of entire tear volume
- inherently unstable
Properties of inner basal layer (mucoid)
- comprised of glycoproteins secreted by goblet cells
- very thin and hydrophilic
What properties must a drug contain to penetrate the cornea?
A balance of hydrophilic and lipophilic properties to go between both the epithelium and stroma
The epithelium can act as a depot/reservoir for ___ drugs
Lipophilic
The stroma can act as a depot/reservoir for ___ drugs
Hydrophilic
Properties of corneal epithelium
- squamous layer with zonula occludens/tight junctions
- resists penetration of hydrophilic drugs when intact
- when eroded –> increased penetration of hydrophilic drugs